Toxicology, ADME & Early Drug Development Plan is a conference dedicated to building an integrated safety testing strategy based on adme and toxicology.
Toxicology, ADME & Early Drug Development Plan covers topics such as:
- Lead Optimization to application for First in Man (FIM) clinical trials
- Absorption, Distribution, Metabolism and Excretion (ADME) and Toxicology studies from
- First human dose prediction
- Synergies between ADME and Toxicology studies during early drug development
- Early Drug Development Plan – studies and critical milestones
- Quality standards during Early Drug Development
- Key regulatory documents & submission of ADME and Toxicology data
Toxicology, ADME & Early Drug Development Plan brings together from Pharmaceutical, Biotech, Biologics, Drug Development, Pharmacology, and Drug Manufacturing with job titles such as:
- Research Scientist / Pre-clinical Scientists
- Project Managers, Project Coordinators
- Toxicologists
- Drug development program managers
- CMC/Manufacturing Scientists and Managers
- Outsourcing managers
- Regulatory Affairs Managers
- Business Managers
- Outsourcing strategyCRO selection Study management and monitoring
- Quality Assurance Professionals
Toxicology, ADME & Early Drug Development Plan will be held on 12-14 Mar 2024.
